ArticleEBioMedicine2016

SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.

Yu-An Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.